Cengild Medical Berhad Statistics

Total Valuation

Cengild Medical Berhad has a market cap or net worth of MYR 233.22 million. The enterprise value is 152.50 million.

Market Cap	233.22M
Enterprise Value	152.50M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	Sep 10, 2024

Share Statistics

Cengild Medical Berhad has 832.91 million shares outstanding. The number of shares has increased by 0.58% in one year.

Current Share Class	n/a
Shares Outstanding	832.91M
Shares Change (YoY)	+0.58%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	68.03%
Owned by Institutions (%)	0.10%
Float	169.20M

Valuation Ratios

The trailing PE ratio is 20.32.

PE Ratio	20.32
Forward PE	n/a
PS Ratio	3.26
PB Ratio	2.08
P/TBV Ratio	2.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.66, with an EV/FCF ratio of -42.17.

EV / Earnings	13.28
EV / Sales	2.13
EV / EBITDA	8.66
EV / EBIT	11.90
EV / FCF	-42.17

Financial Position

The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.07.

Current Ratio	5.48
Quick Ratio	5.37
Debt / Equity	0.07
Debt / EBITDA	0.42
Debt / FCF	-2.09
Interest Coverage	24.13

Financial Efficiency

Return on equity (ROE) is 10.49% and return on invested capital (ROIC) is 6.81%.

Return on Equity (ROE)	10.49%
Return on Assets (ROA)	6.07%
Return on Capital (ROIC)	6.81%
Revenue Per Employee	449,928
Profits Per Employee	72,200
Employee Count	159
Asset Turnover	0.53
Inventory Turnover	21.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.93% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.93%
50-Day Moving Average	0.27
200-Day Moving Average	0.29
Relative Strength Index (RSI)	52.94
Average Volume (20 Days)	662,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cengild Medical Berhad had revenue of MYR 71.54 million and earned 11.48 million in profits. Earnings per share was 0.01.

Revenue	71.54M
Gross Profit	33.31M
Operating Income	13.14M
Pretax Income	16.76M
Net Income	11.48M
EBITDA	16.46M
EBIT	13.14M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 88.26 million in cash and 7.55 million in debt, giving a net cash position of 80.71 million or 0.10 per share.

Cash & Cash Equivalents	88.26M
Total Debt	7.55M
Net Cash	80.71M
Net Cash Per Share	0.10
Equity (Book Value)	112.26M
Book Value Per Share	0.13
Working Capital	82.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.76 million and capital expenditures -17.38 million, giving a free cash flow of -3.62 million.

Operating Cash Flow	13.76M
Capital Expenditures	-17.38M
Free Cash Flow	-3.62M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 46.56%, with operating and profit margins of 18.37% and 16.05%.

Gross Margin	46.56%
Operating Margin	18.37%
Pretax Margin	23.43%
Profit Margin	16.05%
EBITDA Margin	23.01%
EBIT Margin	18.37%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 2.60%.

Dividend Per Share	0.01
Dividend Yield	2.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	53.69%
Buyback Yield	-0.58%
Shareholder Yield	2.01%
Earnings Yield	4.92%
FCF Yield	-1.55%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cengild Medical Berhad has an Altman Z-Score of 8.25.

Altman Z-Score	8.25
Piotroski F-Score	n/a